tradingkey.logo
搜尋

Standard BioTools Inc

LAB
添加自選
0.989USD
+0.004+0.44%
收盤 05/18, 16:00美東報價延遲15分鐘
385.89M總市值
4.95本益比TTM

Standard BioTools Inc

0.989
+0.004+0.44%

關於 Standard BioTools Inc 公司

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Standard BioTools Inc簡介

公司代碼LAB
公司名稱Standard BioTools Inc
上市日期Feb 10, 2011
CEOEgholm (Michael)
員工數量818
證券類型Ordinary Share
年結日Feb 10
公司地址2 Tower Place
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94080
電話16502666000
網址https://www.standardbio.com/
公司代碼LAB
上市日期Feb 10, 2011
CEOEgholm (Michael)

Standard BioTools Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
283.53K
-12.23%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
123.57K
-27.06%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
283.53K
-12.23%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
123.57K
-27.06%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Consumables
36.25M
42.48%
Instruments
25.41M
29.78%
Services and other revenue
23.67M
27.74%
地區USD
名稱
營收
佔比
Europe & Middle East & Africa (EMEA)
35.99M
42.17%
United States
28.40M
33.28%
China
10.90M
12.77%
Asia Pacific excluding China
7.88M
9.24%
Americas excluding United States
2.16M
2.53%
業務
地區
業務USD
名稱
營收
佔比
Consumables
36.25M
42.48%
Instruments
25.41M
29.78%
Services and other revenue
23.67M
27.74%

股東統計

更新時間: 5月14日 週四
更新時間: 5月14日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Casdin Capital, LLC
22.74%
Viking Global Investors LP
15.02%
BlackRock Institutional Trust Company, N.A.
5.77%
MAK Capital One, LLC
4.94%
Vanguard Capital Management, LLC
3.28%
其他
48.23%
持股股東
持股股東
佔比
Casdin Capital, LLC
22.74%
Viking Global Investors LP
15.02%
BlackRock Institutional Trust Company, N.A.
5.77%
MAK Capital One, LLC
4.94%
Vanguard Capital Management, LLC
3.28%
其他
48.23%
股東類型
持股股東
佔比
Hedge Fund
33.98%
Investment Advisor/Hedge Fund
26.18%
Investment Advisor
19.46%
Individual Investor
1.50%
Research Firm
0.64%
Venture Capital
0.62%
Bank and Trust
0.26%
Pension Fund
0.16%
Family Office
0.01%
其他
17.20%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
342
317.36M
81.30%
+773.51K
2025Q4
332
297.38M
77.33%
-28.48M
2025Q3
324
277.96M
72.29%
-27.47M
2025Q2
337
283.64M
74.68%
-28.24M
2025Q1
336
286.88M
75.60%
-24.96M
2024Q4
322
279.84M
75.18%
-22.14M
2024Q3
315
282.67M
78.53%
-14.93M
2024Q2
303
268.49M
74.97%
-14.97M
2024Q1
306
263.03M
71.99%
+131.65M
2023Q4
264
54.09M
66.99%
-14.10M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Casdin Capital, LLC
88.78M
22.76%
+350.00K
+0.40%
Dec 31, 2025
Viking Global Investors LP
58.65M
15.04%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
22.54M
5.78%
+726.65K
+3.33%
Dec 31, 2025
MAK Capital One, LLC
19.29M
4.94%
+3.36M
+21.07%
Dec 31, 2025
Long Focus Capital Management LLC
12.68M
3.25%
+1.32M
+11.58%
Dec 31, 2025
Geode Capital Management, L.L.C.
7.42M
1.9%
-48.22K
-0.65%
Dec 31, 2025
Morgan Stanley Investment Management Inc. (US)
7.23M
1.85%
+1.59M
+28.15%
Dec 31, 2025
State Street Investment Management (US)
6.48M
1.66%
+80.12K
+1.25%
Dec 31, 2025
Hollow Brook Wealth Management, LLC
5.55M
1.42%
-222.36K
-3.85%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.51%
ARK Genomic Revolution ETF
0.33%
iShares Micro-Cap ETF
0.07%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Fidelity MSCI Health Care Index ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.51%
ARK Genomic Revolution ETF
佔比0.33%
iShares Micro-Cap ETF
佔比0.07%
iShares Biotechnology ETF
佔比0.04%
iShares Russell 2000 Value ETF
佔比0.03%
ProShares Hedge Replication ETF
佔比0.02%
ProShares UltraPro Russell2000
佔比0.02%
iShares Russell 2000 ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
Fidelity MSCI Health Care Index ETF
佔比0.01%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI